产品中心 / 产品类型 / 重组蛋白 / 细胞因子 & 细胞因子受体

Recombinant human FGF-23/Fibroblast growth factor 23 Protein (RP01740)

说明书 联系我们 收藏

Recombinant human FGF-23/Fibroblast growth factor 23 Protein was determined by SDS-PAGE with Coomassie Blue, showing a band at 29-34 kDa

All(1)|
货号: RP01740
促销价：   ￥1250
货    期：现货产品
抗体定制服务咨询 |
商城订购

详细信息

种属
human
表达宿主
HEK293 cells
描述
Recombinant human FGF-23/Fibroblast growth factor 23 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Tyr25-Ile251) of human FGF-23/Fibroblast growth factor 23 (Accession #NP_065689.1) fused witha 6×His tag at the C-terminus.
标签
C-His
纯度
> 97% by SDS-PAGE.
内毒素
< 0.1EU/μg
制剂
Lyophilized from a 0.22 μm filtered solution of 20mM MOPS，150mM NaCl，5mM EDTA，2mM DTT, pH 7.4
储存
Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt.
After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week.未开盖的干粉蛋白在 -20°C至-80°C可保存12个月；
复溶之后，蛋白溶液在-20°C及以下可保存3个月，在2-8℃可保存1周。
复溶
Centrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles.收到重组蛋白产品之后请检查蛋白冻干粉末是否贴于瓶底，如果粉末浮起，开盖之前请先低温离心。将蛋白用说明书中指定的缓冲液复溶至0.1-0.5 mg/mL（请注意蛋白复溶浓度不能低于0.1 mg/mL），室温平衡5-10 min保证充分溶解，复溶过程中请不要剧烈涡旋及吹打蛋白溶液。如需长期储存，建议复溶时添加载体蛋白或者稳定剂（如0.1% BSA, 5% HSA, 10% FBS 或者 5% 海藻糖），同时将复溶后的蛋白溶液按照需求进行分装，储存于-20°C至-80°C，随取随用，避免反复冻融。

蛋白复溶计算器

请在蛋白复溶计算器中输入蛋白总质量和所需终浓度，快速计算您需要添加溶液的体积吧！
=
÷

背景信息

Fibroblast growth factor 23 (FGF23) is is an endocrine member of the family of FGFs and mainly produced in the bone and, upon secretion, forms a complex with a FGF receptor and coreceptor αKlotho. FGF23 can exert several endocrine functions, such as acting as a hormone on the kidney, stimulating phosphate excretion and suppressing formation of 1,25(OH)2D3, active vitamin D. Moreover, it has paracrine activities on several cell types, including neutrophils and hepatocytes. FGF23 and phosphate have been revealed to be factors relevant in cancer. FGF23 is particularly significant for those forms of cancer primarily affecting bone (e.g., multiple myeloma) or characterized by bone metastasis.

基因ID
8074
Swiss Prot
Q9GZV9
别名
ADHR; FGFN; HYPF; HFTC2; HPDR2; PHPTC
研究领域
    >